Basics Galecto, Inc. Common Stock IPO Date: October 29, 2020 Sector: Healthcare Industry: Biotech Market Cap: $43.73M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 4.03% Avg Daily Range (30 D): $1.33 | 7.63% Avg Daily Range (90 D): $0.67 | 5.40% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): 1.61M Avg Daily Volume (90 D): 1.76M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 41 Avg Trade Size (Sh.) (90 D): 39 Institutional Trades Total Inst.Trades: 38 Avg Inst. Trade: $1.46M Avg Inst. Trade (30 D): $.97M Avg Inst. Trade (90 D): $.97M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.33M Avg Closing Trade (30 D): $1.04M Avg Closing Trade (90 D): $1.04M Avg Closing Volume: 34.1K     News Nov 10, 2025 @ 4:47 PM Galecto Stock Soars: Strengthens Blood Cancer Pipe... Source: Vandana Singh Nov 10, 2025 @ 12:00 PM Galecto Announces Acquisition of Damora Therapeuti... Source: Galecto, Inc. Sep 25, 2025 @ 9:06 PM 12 Health Care Stocks Moving In Thursday's After-M... Source: Benzinga Staff Writer Feb 6, 2025 @ 1:00 PM Galecto to Participate in Upcoming Investor Confer... Source: N/A Oct 7, 2024 @ 12:45 PM Galecto Completes Strategic Review to Focus on Onc... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-12.11 $-2.36 $-2.6 Diluted EPS $-12.11 $-2.36 $-2.6 Revenue $ .39M $ .04M $ .05M Gross Profit $ $ $ Net Income / Loss $ -15.84M $ -3.1M $ -3.4M Operating Income / Loss $ -16.28M $ -3.16M $ -3.42M Cost of Revenue $ $ $ Net Cash Flow $ -6M $ -2.61M $ -1.73M PE Ratio     Splits Aug 30, 2024:   1:25